My watch list  


News Immunogenicity

  • Zika vaccine induces strong immune response in three phase 1 studies

    Three Phase 1 human clinical trials evaluating an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it was safe and well-tolerated in healthy adults and induced a robust immune response. Each of the three studies included in the paper was designed to address a unique question more

  • Antitope and Synthon announce collaboration

    Antitope Limited, an Abzena company, announced that it will collaborate with Synthon Biopharmaceuticals BV, to assess the potential immunogenicity of candidate antibodies for Synthon’s ADC programmes. Antitope will use its EpiScreen™ technology, a highly accurate and sensitive ex vivo human T cell a more

  • SEEK announces clinical proof of efficacy in HIV vaccine Phase Ib/II human trial

    SEEK, a privately owned biopharmaceutical company specializing in immunology, announced that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after jus more

All news on immunogenicity

White papers Immunogenicity

Publications Immunogenicity

All publications on immunogenicity


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE